Health industry publications

The landscape of health policy, technology, and operations demands that professionals stay on top of key trends in the healthcare payer and provider, life sciences and pharmaceutical industries. PricewaterhouseCoopers' health industry publications focus on trends as well as key insights and best practices.






Publication: View: Winter 08
View: Winter 08 - February 08

Healthy choices? What election-year healthcare reform proposals mean for the future of employer-sponsored health insurance.

Research rewired: Merging care and research information to improve knowledge discovery
Today's ad hoc methods of managing research information are beginning to strain under increasing demands for new drugs, more personalized medicine, better diagnostic tools, and post-market safety monitoring. This report investigates the benefits, barriers, and emerging approaches to creating an integrated information environment that will help to shape scientific diagnostic, drug, and device discovery in the future. See more

Top Eight Health Industry Issues in 2008
Health organizations face a pivotal year in 2008 as they anticipate the wildcard outcome of the presidential election. Meanwhile, they must prepare for impending changes — pharmaceutical and life sciences companies are adapting to a new safety agenda from the FDA including the agency’s expanded authority over post-market drug safety. See more

Pharma 2020: The vision: Which path will you take?
The current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.

Recapturing the vision: Restoring trust in the pharmaceutical industry by translating expectations into actions
This report provides an in-depth analysis of one of the most pressing issues facing the global pharmaceutical industry today—its reputation and how it deals with perceptions about its business and operational models. It was co-developed by the Pharmaceutical Industry Group and the firm's Health Research Institute.

The quality conundrum: Practical approaches for enhancing patient care
More than a year in development, "The quality conundrum" is a compilation of essays by PwC subject matter experts, discussions with selected clients and insights from our interviews with health industry leaders in the United States and around the world. It explores the barriers that have made healthcare quality improvements difficult to achieve, and outlines a clear path to progress. It includes a discussion of quality from the patient's perspective, in the journey across the health care system.


Contacts
Carter Pate
US health industries leader
Tel: +1 (703) 918 1111
Mark Simon
US pharmaceuticals/life sciences leader
Tel: +1 (973) 236-5410
Paul Veronneau
US healthcare payer leader
Tel: +1 (860) 241-7568
Robert Dondero
US healthcare provider leader
Tel: +1 (678) 419 1057
David Chin, MD
Health Research Institute leader
Tel: +1 (617) 530 4381
Todd Hall
Health industries marketing leader
Tel: +1 (617) 530 4185

© 2007-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
Accessibility information Skip navigation Countries online